Mark Butler made this point at the recent GBMA Summit. He is currently grappling with the PBAC's recommendation to reimburse a GLP-1 therapy for weight loss. The minister essentially acknowledged that he has to find the money, which is the nature of the system. Simply arguing for more without a focus on how to achieve it is frankly akin to a beauty pageant contestant calling for world peace.
PBS spending is driven less by explicit fiscal choices and more by the flow of recommendations
February 15, 2026 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Medicines Australia seeks answers on AI in HTA process
September 23, 2026 - - Latest News -
The prevention gap and inside Sally Panton's bet on cellular health
September 23, 2026 - - Latest News -
Pfizer 'deeply disappointed' in response to PBAC refusing to move on price
September 23, 2026 - - Latest News -
Lilly goes direct with a patient platform for its non-PBS medicines
September 23, 2026 - - Latest News -
A 'multistakeholder' reference group to shadow agreement negotiations
September 23, 2026 - -
If there is a productivity gain in the process, then it should be passed on
September 22, 2026 - - Latest News -
Given the official use of AI, a cease and desist would not be unreasonable
September 22, 2026 - - Latest News
